Latoxan
Latoxan is a French specialty biochemical supplier founded in 1982 that produces and distributes over 300 animal venoms, purified venom peptides, and plant-derived compounds to pharmaceutical companies and academic research centres worldwide, with WHO-compliant production and full donor traceability.
- Company typePrivate
- Founded1982
- HeadquartersPortes-lès-valence, France
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Latoxan does
Latoxan S.A.S. is a French specialty biochemical supplier founded in 1982 and headquartered in Portes-lès-Valence, France, that produces and distributes animal venoms, purified venom peptides and toxins, and plant-derived compounds for the pharmaceutical industry, academic research centres, and drug discovery screening programs. The company's core catalog comprises over 300 venoms sourced globally — including more than 150 snake venoms (viper, elapid, crotalid, colubrid), approximately 70 scorpion venoms, plus spider, batrachian, and other arthropod venoms — extracted from animals kept in Latoxan's own breeding facilities or captured in the wild and released after milking. Production complies with the WHO Guidelines on Production, Control and Regulation of Snake Antivenom Immunoglobulins and with European animal welfare regulations, and each shipment includes a certificate of analysis, certificate of origin, health veterinary certificate, and Venom Production Master File with traceability to individual donor animals.
Beyond raw venoms, Latoxan sells purified venom peptides and toxins (95-98% purity) such as 3-finger toxins, proteases, phospholipases, and ion-channel modulators for research protocols and diagnostic applications including blood coagulation. Plant molecules and small molecules are sourced through an exclusive partnership with a foreign academic institution specialized in Plant Biochemistry and Pharmacology (the Biotoxan line). The company also operates two additional sub-brands: Peptoxan, an in-house drug discovery screening program in antimicrobial, analgesic, anticancer, and bioinsecticide domains; and Kitoxan, a custom service offering for life sciences clients.
Latoxan runs a sales-led, transactional go-to-market model with direct B2B e-commerce through its website, plus email, fax, phone, and bank transfer or PayPal payment. Unit pricing is published per milligram or gram (e.g., Apis mellifera venom 1 g at €330, Leucovorisine 500 mg at €480) with a €25 processing fee for orders under €100 and quantity discounts for bulk orders. The company maintains authorized distributors in the USA (Accurate Chemical & Scientific), China (Beijing Biolead), Japan (Funakoshi), Hong Kong (Hong Kong Biolead), and Italy (Societa Italiana Chimici), with France and the rest of the world served directly from the Portes-lès-Valence facility. Latoxan is privately held, founder-owned, with no disclosed venture capital, private equity, or parent-company backing, and reports a 1-10 employee headcount.
Latoxan firmographics
Firmographics- Name
- Latoxan
- Legal name
- LATOXAN S.A.S. - Laboratoire de Toxines Animales et Animaux Venimeux
- Website
- https://latoxan.com
- Company type
- Private
- Founded year
- 1982
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Latoxan is a French specialty biochemical supplier founded in 1982 that produces and distributes over 300 animal venoms, purified venom peptides, and plant-derived compounds to pharmaceutical companies and academic research centres worldwide, with WHO-compliant production and full donor traceability.
- Ownership category
- akta.pro rank
Where Latoxan is headquartered
LocationHeadquarters
- HQ city
- Portes-lès-valence
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Latoxan business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Venom Sales: Sale of pure venoms from snakes (150+ species), scorpions (70+ species), spiders, batrachians, and other arthropods. Venoms sold in quantities from 10mg to 10g depending on species.
- Venom Peptides & Toxins: Purified venom peptides and toxins including 3-finger toxins, proteases, phospholipases, and ion-channel modulators with 95-98% purity for research and drug discovery applications.
- Plant Compounds: Plant molecules and extracts from Central Asian steppe and mountains through exclusive academic partnership. Includes various pharmacological compounds.
- Bulk Orders: Quantity discounts available for bulk orders. Custom quotations provided for larger quantities or non-listed products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Unit pricing per mg/g for venoms and toxins |
| Unit Pricing | Pay-as-you-go | Plant molecules - Leucovorisine example |
| Other | Multi-year contract | Bulk and custom quotations |
Go-to-market motion2 records
Distribution channels8 records
Marketing channels4 records
Latoxan product offering
Product offeringCore offering
Latoxan produces, extracts, and supplies animal venoms and purified venom-derived compounds (peptides, toxins) for life science research and pharmaceutical drug discovery. Its catalogue covers more than 300 venoms from snakes (150+ species), scorpions (70+ species), spiders, and batrachians, plus plant-derived molecules sourced through an exclusive academic partnership. Products are sold by weight (typically 10 mg to 10 g) with full donor traceability and regulatory documentation.
Product overview
Latoxan is a specialized biochemical supplier offering venoms, toxins, and plant substances through three main product lines: Pure Venoms (snake, scorpion, spider, and batrachian venoms), Toxins & Plant Substances (venom peptides, plant molecules, screening libraries), and Other Products. The company operates three sub-brands: Biotoxan (plant extracts and molecules), Peptoxan (venom-based drug discovery research), and Kitoxan (custom life sciences services). With over 300 different venoms available, Latoxan supplies pharmaceutical companies, academic institutions, and research laboratories worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- Biotoxan: Range of plant products offering pure molecules and unique plant extracts processed from plants endemic to Central Asian steppe and mountains.
- Peptoxan
- Kitoxan
Products and services
- Pure Venoms Venoms from snakes, scorpions, and batrachians with over 300 different venoms worldwide available, produced under WHO-compliant processes for antivenom production and supplied to pharmaceutical industry and academic research.
- Toxins & Plant Substances Venom toxins, plant compounds, plant small molecules, and screening libraries with most molecules provided at purity ≥98% for drug discovery and research applications.
- Snake Venoms More than 150 different snake venoms including viper, elapid, crotalid, and colubrid venoms, available in quantities from 10 mg to 10 grams for research, drug discovery, and manufacturing.
- Scorpion Venoms About 70 different scorpion venoms available in quantities from 10 mg to 1 gram for research and drug discovery applications.
- Spider Venoms Various spider venoms available in quantities from 10 mg to 100 mg for research and drug discovery.
- Batrachian Venoms Various batrachian (amphibian) venoms available in quantities from 10 mg to 1 gram for research and drug discovery.
- Venom Peptides & Toxins Venom peptides and venom toxins purified from Latoxan's own venoms with purity ranging from 95-98%, including 3-finger toxins, proteases, phospholipases, and ion-channel modulators, used as tools in research protocols, blood coagulation diagnostics, and drug discovery screening programs.
- Biotoxan — Plant Molecules and Extracts Range of plant products offering pure molecules and unique plant extracts processed from plants endemic to Central Asian steppe and mountains, sourced through an exclusive partnership with an academic institute.
- Kitoxan — Custom Life Sciences Services Custom services for Life Sciences providing venom-derived high therapeutic potential peptides for research applications targeting nervous system, muscle, hemostasis, kidneys, heart, blood circulation, and ion channels.
Quantifiable outcome
- Venoms are produced under strictly controlled conditions from animals collected worldwide or born and reared in breeding facilities
- +1 more outcomes
Companies that use Latoxan
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Latoxan technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Latoxan partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Foreign Academic Institution (Plant Biochemistry and Pharmacology)coreExclusive partnership with a foreign academic Institution specialized in Plant Biochemistry and Pharmacology for sourcing plant molecules from Central Asian steppe and mountains. Plants harvest is controlled and authorized by local authorities.
- Accurate Chemical & Scientific CorporationminorAuthorized distributor for USA market located at 554 Westbury Avenue, Carle Place, NY 11514, Westbury, USA. Phone: +1 516 333 2221.
- Beijing Biolead International Trading Co.,LtdminorAuthorized distributor for China located at Room 603, 6th floor, Building 4, ID park, Duyang South Street, Shunyi District, Beijing (101300), P.R. China.
- Funakoshi Co. Ltd.minorAuthorized distributor for Japan located at 9-7, Hongo 2-Chome, Bunkyo-ku, Tokyo 113, JAPAN.
- Hong Kong Biolead International Trading LimitedminorAuthorized distributor for Hong Kong located at Flat B11, 22/F, Hoover Industrial Building, 26-38 Kwai Cheong Road, Kwai Chung, N.T., Hong Kong.
- Societa Italiana Chimici Divisione Scientifica r.lminorAuthorized distributor for Italy located at Via Rio nell'Elba 140, 00138 Roma, ITALY.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Latoxan competitors and assessment
Company assessmentDirect peers
- Cayman Chemical: US-based supplier of biochemical research tools including venom-derived compounds, natural products, and assay reagents. Comparable to Latoxan in supplying high-purity research molecules to pharma and academic labs.
- Smartox Biotechnology: French-based supplier of animal venoms, synthetic peptides, and screening libraries for ion-channel research. Closest direct competitor to Latoxan, operating in the same venom/toxin catalog with overlapping pharma and academic customers.
- Tocris Bioscience (Bio-Techne): Established supplier of high-purity life science research reagents including venom-derived peptides and ion-channel modulators. Direct competitor in purified peptides and toxins for pharma R&D, with a significantly larger catalog and global reach.
- Peptide Institute (Japan): Japanese manufacturer of synthetic peptides and biochemical reagents for research and pharmaceutical use. Comparable to Latoxan's Kitoxan custom peptide services and pharmaceutical-grade reagent business.
- Alomone Labs: Israel-based supplier of ion-channel toxins, venom peptides, and related research reagents. Directly comparable to Latoxan's venom peptide and toxin product line, serving the same drug discovery and electrophysiology research market.
Broad incumbents
- Sigma-Aldrich / Merck (MilliporeSigma): Global life science giant offering an extensive catalog of biochemicals, venom-derived compounds, and research reagents. Broad incumbent that overlaps with Latoxan's portfolio but does not specialize in fresh venoms or single-donor traceability.
- MedChemExpress: Large-scale supplier of research chemicals, inhibitors, peptides, and natural products. Competes with Latoxan on price-breadth across reagents but lacks venom-production specialization.
Emerging players
- Venomtech: UK-based specialist supplier of venoms and venom fractions for drug discovery research. Direct niche competitor in the venom-to-discovery value chain, smaller and more focused than Latoxan.
- Torrey Pines Biolabs / CPC Scientific: Custom peptide and biochemical service provider supporting life science research. Comparable to Latoxan's Kitoxan custom services line, though typically without venom sourcing depth.
- Alpha Diagnostics International: Supplier of antibodies, diagnostic reagents, and venom-derived research tools. Adjacent to Latoxan in the life science reagent market with some overlap in venom-related applications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Latoxan social profiles
Digital presenceLatoxan compliance and trust
Trust signalCompliance2 records
Latoxan financial estimates
Financial estimateRevenue estimate
Valuation estimate
Latoxan leadership team
Management profileNumber of profiles
Latoxan funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Latoxan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Latoxan
What does Latoxan do?
Latoxan produces, extracts, and supplies animal venoms and purified venom-derived compounds (peptides, toxins) for life science research and pharmaceutical drug discovery. Its catalogue covers more than 300 venoms from snakes (150+ species), scorpions (70+ species), spiders, and batrachians, plus plant-derived molecules sourced through an exclusive academic partnership. Products are sold by weight (typically 10 mg to 10 g) with full donor traceability and regulatory documentation.
Is Latoxan a public or private company?
Latoxan is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Latoxan founded?
Latoxan was founded in 1982. It employs 1 to 10 people.
Where is Latoxan based?
Latoxan is headquartered in Portes-lès-valence, France, in the Europe region.
How does Latoxan make money?
Four revenue lines are on record. Venom Sales are the primary driver. The others are venom Peptides & Toxins, plant Compounds and bulk Orders.
Who are Latoxan's main competitors?
Direct peers on record are Cayman Chemical, Smartox Biotechnology, Tocris Bioscience (Bio-Techne), Peptide Institute (Japan) and Alomone Labs. Broad incumbents are Sigma-Aldrich / Merck (MilliporeSigma) and MedChemExpress. Emerging players are Venomtech, Torrey Pines Biolabs / CPC Scientific and Alpha Diagnostics International.
Does Latoxan have an API?
No public API is recorded for Latoxan.